Catalyst Wire Dossier Catalyst Wire Dossier

XS003 (Nilotinib)

nilotinib · Xspray Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS003 (Nilotinib), covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability Study of XS003 (Nilotinib) [Phase 1]

See pricing